Eric Lawrence
About Eric Lawrence
Eric Lawrence is the Director of Global Alliance Management at Bristol Myers Squibb in Princeton, New Jersey, with over 15 years of experience in the biopharmaceutical industry.
Current Role at Bristol Myers Squibb
Eric Lawrence currently serves as the Director of Global Alliance Management at Bristol Myers Squibb in Princeton, New Jersey. He began this role in May 2020 and is responsible for managing strategic partnerships to drive alliance success.
Previous Roles at Bristol Myers Squibb
Prior to his current position, Eric Lawrence held several roles at Bristol Myers Squibb. These included Associate Director, Clinical Biomarker Specialty Lab Alliance Lead (2018-2020), Outsourcing Manager (2017-2018), and Project Manager of Biologics Development Outsourcing (2015-2017). He has also worked as Research Scientist II (2013-2015), Research Scientist I (2010-2013), and Associate Scientist II (2007-2010) in various locations including Hopewell and Lawrenceville, NJ.
Experience at Centocor
Before joining Bristol Myers Squibb, Eric Lawrence worked at Centocor as an Associate Scientist II from 2005 to 2007. This role further honed his expertise and prepared him for his subsequent positions in the biopharmaceutical industry.
Educational Background
Eric Lawrence has a strong educational foundation. He holds an MBA from Rutgers University (2015-2017) and a Business Essentials Certificate from The Wharton School (2005-2007). He also earned a Master's in Biotechnology from the University of Pennsylvania (2000-2003) and a BS in Biology from Rutgers University (1994-1998).
Industry Expertise
With over 15 years of experience in the biopharmaceutical sector, Eric Lawrence has a diverse background. His expertise spans clinical operations, business planning, budgeting, outsourcing management, procurement, operational excellence, resource modeling, strategy development, and discovery research. He has demonstrated proven leadership in developing external partnerships and supporting all facets of the drug development process from discovery through clinical trials.